Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10181708AEP2272959A1 (en) | 1993-05-12 | 1994-05-12 | BMP-11 compositions |
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6146493A | 1993-05-12 | 1993-05-12 | |
EP03021107AEP1378572B1 (en) | 1993-05-12 | 1994-05-12 | Bmp-11 compositions |
EP94917361AEP0698094B1 (en) | 1993-05-12 | 1994-05-12 | Bmp-11 compositions |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03021107ADivisionEP1378572B1 (en) | 1993-05-12 | 1994-05-12 | Bmp-11 compositions |
Publication Number | Publication Date |
---|---|
EP1770161A2 EP1770161A2 (en) | 2007-04-04 |
EP1770161A3true EP1770161A3 (en) | 2008-04-23 |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06022258AWithdrawnEP1770161A3 (en) | 1993-05-12 | 1994-05-12 | BMP-11 compositions |
EP10181708AWithdrawnEP2272959A1 (en) | 1993-05-12 | 1994-05-12 | BMP-11 compositions |
EP03021107AExpired - LifetimeEP1378572B1 (en) | 1993-05-12 | 1994-05-12 | Bmp-11 compositions |
EP94917361AExpired - LifetimeEP0698094B1 (en) | 1993-05-12 | 1994-05-12 | Bmp-11 compositions |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10181708AWithdrawnEP2272959A1 (en) | 1993-05-12 | 1994-05-12 | BMP-11 compositions |
EP03021107AExpired - LifetimeEP1378572B1 (en) | 1993-05-12 | 1994-05-12 | Bmp-11 compositions |
EP94917361AExpired - LifetimeEP0698094B1 (en) | 1993-05-12 | 1994-05-12 | Bmp-11 compositions |
Country | Link |
---|---|
US (7) | US5639638A (en) |
EP (4) | EP1770161A3 (en) |
JP (2) | JP3681069B2 (en) |
KR (1) | KR100227406B1 (en) |
AT (2) | ATE343635T1 (en) |
AU (1) | AU678582B2 (en) |
BR (1) | BR9406715A (en) |
CA (1) | CA2161808C (en) |
DE (2) | DE69433530T2 (en) |
DK (2) | DK0698094T3 (en) |
ES (2) | ES2274157T3 (en) |
FI (1) | FI119696B (en) |
NO (1) | NO320119B1 (en) |
OA (1) | OA10191A (en) |
PT (2) | PT1378572E (en) |
WO (1) | WO1994026892A1 (en) |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE20004692U1 (en) | 2000-03-14 | 2001-07-26 | Sofamor Danek GmbH, 94469 Deggendorf | Vertebral implant for screwing into an intervertebral space |
US6150328A (en) | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
ATE238417T1 (en)* | 1991-11-04 | 2003-05-15 | Inst Genetics Llc | RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE |
US20080139474A1 (en)* | 1991-11-04 | 2008-06-12 | David Israel | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
US7393682B1 (en)* | 1993-03-19 | 2008-07-01 | The Johns Hopkins University School Of Medicine | Polynucleotides encoding promyostatin polypeptides |
US20030074680A1 (en)* | 1993-03-19 | 2003-04-17 | Johns Hopkins University School Of Medicine | Growth differentiation factor-8 |
US6465239B1 (en)* | 1993-03-19 | 2002-10-15 | The John Hopkins University School Of Medicine | Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species |
ES2274157T3 (en)* | 1993-05-12 | 2007-05-16 | Genetics Institute, Llc | BMP-11 COMPOSITIONS. |
US6291206B1 (en) | 1993-09-17 | 2001-09-18 | Genetics Institute, Inc. | BMP receptor proteins |
ATE319823T1 (en) | 1993-12-07 | 2006-03-15 | Inst Genetics Llc | BMP-12, BMP-13 AND TENDON-INDUCING COMPOSITIONS CONTAINING SAME |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
US7332575B2 (en)* | 1994-03-18 | 2008-02-19 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
US5906827A (en)* | 1994-06-03 | 1999-05-25 | Creative Biomolecules, Inc. | Matrix for the manufacture of autogenous replacement body parts |
US20030167492A1 (en) | 1994-07-08 | 2003-09-04 | Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same |
US6008434A (en) | 1994-07-08 | 1999-12-28 | Johns Hopkins University School Of Medicine | Growth differentiation factor-11 transgenic mice |
ES2251721T3 (en)* | 1994-07-08 | 2006-05-01 | The Johns Hopkins University School Of Medicine | GROWTH DIFFERENTIATION FACTOR-11. |
US5846770A (en)* | 1994-11-22 | 1998-12-08 | Genetics Institute, Inc. | DNA molecules encoding human chordin |
US5645084A (en)* | 1995-06-07 | 1997-07-08 | Danek Medical, Inc. | Method for spinal fusion without decortication |
US5635372A (en)* | 1995-05-18 | 1997-06-03 | Genetics Institute, Inc. | BMP-15 compositions |
HU222664B1 (en) | 1995-06-05 | 2003-09-29 | Genetics Institute, Llc | Use of Bone Morphogenetic Protein (BMP) for Regeneration of Functional Link between Bone and tendon or Tape |
US5902785A (en)* | 1995-06-06 | 1999-05-11 | Genetics Institute, Inc. | Cartilage induction by bone morphogenetic proteins |
US5700774A (en)* | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
US5965403A (en)* | 1996-09-18 | 1999-10-12 | Genetics Institute, Inc. | Nucleic acids encoding bone morphogenic protein-16 (BMP-16) |
US6037519A (en)* | 1997-10-20 | 2000-03-14 | Sdgi Holdings, Inc. | Ceramic fusion implants and compositions |
EP0973926A1 (en) | 1997-03-14 | 2000-01-26 | Selective Genetics, Inc. | Adenoviral vectors with modified tropism |
US20010016646A1 (en) | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
US7041641B2 (en) | 1997-03-20 | 2006-05-09 | Stryker Corporation | Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
WO1998054572A1 (en) | 1997-05-30 | 1998-12-03 | Creative Biomolecules, Inc. | Methods for evaluating tissue morphogenesis and activity |
US5972368A (en) | 1997-06-11 | 1999-10-26 | Sdgi Holdings, Inc. | Bone graft composites and spacers |
AU745122B2 (en) | 1997-07-30 | 2002-03-14 | Emory University | Novel bone mineralization proteins, DNA, vectors, expression systems |
US7923250B2 (en) | 1997-07-30 | 2011-04-12 | Warsaw Orthopedic, Inc. | Methods of expressing LIM mineralization protein in non-osseous cells |
US6891082B2 (en)* | 1997-08-01 | 2005-05-10 | The Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a truncated activintype II receptor |
US6696260B1 (en)* | 1997-08-01 | 2004-02-24 | The Johns Hopkins University School Of Medicine | Methods to identify growth differentiation factor (GDF) binding proteins |
AU8666398A (en)* | 1997-08-01 | 1999-02-22 | Johns Hopkins University School Of Medicine, The | Methods to identify growth differentiation factor (gdf) receptors |
US20020052026A1 (en) | 1997-10-08 | 2002-05-02 | Steven M. Vicik | Methods of refolding proteins |
US6511509B1 (en) | 1997-10-20 | 2003-01-28 | Lifenet | Textured bone allograft, method of making and using same |
WO1999024057A2 (en)* | 1997-11-07 | 1999-05-20 | Genetics Inst | Neuronal uses of bmp-11 |
US6027917A (en) | 1997-12-10 | 2000-02-22 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
US20030036629A1 (en)* | 1997-12-12 | 2003-02-20 | Barry Foster | Novel tgf-beta protein purification methods |
US6004937A (en)* | 1998-03-09 | 1999-12-21 | Genetics Institute, Inc. | Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11] |
US7147839B2 (en) | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
WO2000006716A1 (en)* | 1998-07-28 | 2000-02-10 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-11 |
AU5341999A (en) | 1998-08-06 | 2000-02-28 | Sdgi Holdings, Inc. | Composited intervertebral bone spacers |
US6849255B2 (en)* | 1998-08-18 | 2005-02-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods and compositions for enhancing cartilage repair |
US6727224B1 (en) | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
EP1181041A2 (en)* | 1999-04-30 | 2002-02-27 | Curis, Inc. | Morphogen-induced enhancement of fertility |
US7189392B1 (en) | 1999-10-15 | 2007-03-13 | Genetics Institute, Llc | Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins |
JP4672947B2 (en) | 1999-12-06 | 2011-04-20 | ウォーソー・オーソペディック・インコーポレーテッド | Intervertebral disc treatment apparatus and method |
US20030082233A1 (en)* | 2000-12-01 | 2003-05-01 | Lyons Karen M. | Method and composition for modulating bone growth |
US6752831B2 (en) | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
US8758438B2 (en) | 2000-12-08 | 2014-06-24 | Warsaw Orthopedic, Inc. | Implant for orthopedic applications |
US7141392B2 (en) | 2001-01-09 | 2006-11-28 | Queen Mary And Westfield College | Latent fusion protein |
GB0100551D0 (en)* | 2001-01-09 | 2001-02-21 | Queen Mary & Westfield College | Protein |
TWI329129B (en) | 2001-02-08 | 2010-08-21 | Wyeth Corp | Modified and stabilized gdf propeptides and uses thereof |
EP1790726B1 (en)* | 2001-02-08 | 2013-07-03 | Wyeth LLC | Modified and stabilized GDF propeptides and uses thereof |
KR100420798B1 (en)* | 2001-02-10 | 2004-03-02 | (주)알에이싸이언스 | Peptide vector |
US7226587B2 (en) | 2001-06-01 | 2007-06-05 | Wyeth | Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
TWI267378B (en) | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
US6798160B2 (en)* | 2001-11-02 | 2004-09-28 | Honda Giken Kogyo Kabushiki Kaisha | Electric working machine |
KR100955410B1 (en)* | 2001-11-27 | 2010-05-06 | 타키론 가부시기가이샤 | Implant Materials and Manufacturing Method Thereof |
CH695985A5 (en)* | 2002-01-21 | 2006-11-15 | Straumann Holding Ag | Surface-modified implants. |
BR0307871A (en) | 2002-02-21 | 2005-04-12 | Wyeth Corp | Folistatin Domain-Containing Proteins |
US7192717B2 (en) | 2002-02-21 | 2007-03-20 | Wyeth | GASP1: a follistatin domain containing protein |
CN1665525A (en)* | 2002-05-17 | 2005-09-07 | 惠氏公司 | Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
AU2003259765B2 (en)* | 2002-08-13 | 2009-01-22 | Wyeth | Peptides as solubilizing excipients for transforming growth factor Beta proteins |
EP1549747A4 (en)* | 2002-09-16 | 2006-08-23 | Wyeth Corp | Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
AR047392A1 (en) | 2002-10-22 | 2006-01-18 | Wyeth Corp | NEUTRALIZATION OF ANTIBODIES AGAINST GDF 8 AND ITS USE FOR SUCH PURPOSES |
US20040223966A1 (en)* | 2002-10-25 | 2004-11-11 | Wolfman Neil M. | ActRIIB fusion polypeptides and uses therefor |
JP5110877B2 (en) | 2003-06-02 | 2012-12-26 | ワイス・エルエルシー | Use of myostatin (GDF8) inhibitors in combination with corticosteroids to treat neuromuscular disorders |
KR20060133961A (en) | 2003-09-12 | 2006-12-27 | 와이어쓰 | Injectable Calcium Phosphate Solid Rods and Pastes for Bone Formation Protein Delivery |
EP1737734B1 (en) | 2004-03-10 | 2010-08-18 | Scil Technology GmbH | Coated implants, their manufacturing and use thereof |
EP1740609A2 (en) | 2004-04-27 | 2007-01-10 | Research Development Foundation | Antagonism of tgf-beta superfamily receptor signaling |
JP5201987B2 (en) | 2004-05-25 | 2013-06-05 | ストライカー コーポレイション | Use of morphogenic proteins to treat cartilage defects |
US7749268B2 (en) | 2004-05-26 | 2010-07-06 | Warsaw Orthopedic, Inc. | Methods for treating the spine |
BRPI0514253A (en)* | 2004-08-12 | 2008-06-03 | Wyeth Corp | combination therapy for diabetes, obesity and cardiovascular disease using compositions containing gdf-8 inhibitors |
US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
WO2006081379A1 (en)* | 2005-01-26 | 2006-08-03 | Wyeth | Use of sfrps as markers of bmp activity |
CA2601086A1 (en)* | 2005-03-23 | 2006-10-12 | Wyeth | Detection of an immune response to gdf-8 modulating agents |
AU2006230434A1 (en)* | 2005-03-30 | 2006-10-05 | Wyeth | Methods for stimulating hair growth by administering BMPs |
US8506646B2 (en) | 2005-04-29 | 2013-08-13 | Warsaw Orthopedic, Inc. | Multi-purpose medical implant devices |
US20060247790A1 (en)* | 2005-04-30 | 2006-11-02 | Mckay William F | Shaped osteochondral grafts and methods of using same |
JP5052517B2 (en) | 2005-10-06 | 2012-10-17 | イーライ リリー アンド カンパニー | Anti-myostatin antibody |
UA92504C2 (en) | 2005-10-12 | 2010-11-10 | Эли Лилли Энд Компани | Anti-myostatin monoclonal antibody |
US8147860B2 (en) | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
WO2007092622A2 (en) | 2006-02-09 | 2007-08-16 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
JP5362554B2 (en) | 2006-05-17 | 2013-12-11 | ストライカー コーポレイション | Use of soluble morphogenic proteins to treat cartilage defects |
WO2008005427A2 (en) | 2006-06-30 | 2008-01-10 | Biomimetic Therapeutics, Inc. | Pdgf-biomatrix compositions and methods for treating rotator cuff injuries |
US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
US8524265B2 (en) | 2006-08-17 | 2013-09-03 | Warsaw Orthopedic, Inc. | Medical implant sheets useful for tissue regeneration |
RS52787B (en) | 2006-09-05 | 2013-10-31 | Eli Lilly And Company | Anti-myostatin antibodies |
JP2008104401A (en)* | 2006-10-25 | 2008-05-08 | Kyoto Univ | Method for in vitro proliferation of spermatogonial stem cells |
AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
ES2447516T3 (en) | 2006-12-21 | 2014-03-12 | Stryker Corporation | Sustained release formulations comprising BMP-7 crystals |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
US8058237B2 (en) | 2007-08-07 | 2011-11-15 | Advanced Technologies & Regenerative Medicine, LLC | Stable composition of GDF-5 and method of storage |
ES2474194T3 (en) | 2008-02-13 | 2014-07-08 | Keith Hruska | PMO-7 for use in the treatment of neointimal hyperplasia |
CN102026619A (en) | 2008-04-14 | 2011-04-20 | 先进科技及再生医学有限责任公司 | Liquid buffered GDF-5 formulations |
MX2011002555A (en) | 2008-09-09 | 2011-08-03 | Biomimetic Therapeutics Inc | Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries. |
US20100204124A1 (en) | 2009-02-12 | 2010-08-12 | Mary Elizabeth Pecquet Goad | Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members |
CN102369016A (en) | 2009-02-12 | 2012-03-07 | 史赛克公司 | Peripheral administration of proteins comprising members of the TGF-beta superfamily for the treatment of systemic disorders and diseases |
WO2010110974A1 (en) | 2009-03-24 | 2010-09-30 | Stryker Corporation | Methods and compositions for tissue engineering |
US8609127B2 (en) | 2009-04-03 | 2013-12-17 | Warsaw Orthopedic, Inc. | Medical implant with bioactive material and method of making the medical implant |
US20110002897A1 (en) | 2009-06-11 | 2011-01-06 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
US9399086B2 (en) | 2009-07-24 | 2016-07-26 | Warsaw Orthopedic, Inc | Implantable medical devices |
US20110224138A1 (en) | 2009-09-09 | 2011-09-15 | Julie Krop | Methods for treating pain induced by injuries and diseases of an articular joint |
US20110224410A1 (en) | 2009-09-17 | 2011-09-15 | Hile David | Buffers for Controlling the pH of Bone Morphogenetic Proteins |
WO2011087768A1 (en) | 2009-12-22 | 2011-07-21 | Stryker Corporation | Bmp-7 variants with reduced immunogenicity |
NZ601559A (en) | 2010-02-22 | 2014-10-31 | Biomimetic Therapeutics Llc | Platelet-derived growth factor compositions and methods for the treatment of tendinopathies |
WO2011139594A2 (en) | 2010-04-27 | 2011-11-10 | Medtronic, Inc. | Artificial bursa for intra-articular drug delivery |
CN103079585B (en) | 2010-08-20 | 2015-09-30 | 惠氏有限责任公司 | Through the BMP of design |
US9688735B2 (en) | 2010-08-20 | 2017-06-27 | Wyeth Llc | Designer osteogenic proteins |
US8998925B2 (en) | 2011-06-20 | 2015-04-07 | Rdc Holdings, Llc | Fixation system for orthopedic devices |
WO2012177759A1 (en) | 2011-06-20 | 2012-12-27 | Rdc Holdings, Llc | System and method for repairing joints |
EP2828289B1 (en)* | 2012-03-19 | 2020-02-26 | The Brigham and Women's Hospital, Inc. | Growth differentiation factor (gdf) 11 for treatment of age-related cardiovascular condition |
US10034945B2 (en) | 2012-07-13 | 2018-07-31 | Trustees Of Tufts College | Silk powder compaction for production of constructs with high mechanical strength and stiffness |
US20160120945A1 (en)* | 2013-02-15 | 2016-05-05 | The Brigham And Women's Hospital, Inc. | Thymic Regeneration |
US10092627B2 (en) | 2013-04-08 | 2018-10-09 | President And Fellows Of Harvard College | Methods and compositions for rejuvenating skeletal muscle stem cells |
AU2014253753B2 (en) | 2013-04-19 | 2017-03-30 | Theracell, Inc. | Demineralized bone fibers having controlled geometry and shapes and methods thereof |
WO2015070076A2 (en)* | 2013-11-08 | 2015-05-14 | President And Fellows Of Harvard College | Methods and compositions for rejuvenating neuromuscular junctions |
US10017566B2 (en) | 2013-11-12 | 2018-07-10 | The Brigham And Women's Hospital, Inc. | Growth differentiation factor (GDF) for treatment of diastolic heart failure |
WO2016123583A1 (en) | 2015-01-29 | 2016-08-04 | Theracell, Inc. | Demineralized bone fiber composition for use in minimally invasive surgery |
EP3271380B1 (en) | 2015-03-17 | 2021-08-11 | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. | Purification of bone morphogenetic proteins (bmps) |
JP2018517527A (en) | 2015-06-17 | 2018-07-05 | ウォーソー・オーソペディック・インコーポレーテッド | Implants containing oxysterol and methods of use thereof |
EP3368016B1 (en) | 2015-10-26 | 2020-10-21 | President and Fellows of Harvard College | Reduced and oxidized polysaccharides and methods of use thereof |
WO2017120450A1 (en) | 2016-01-06 | 2017-07-13 | President And Fellows Of Harvard College | Treatment with gdf11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis |
KR101810385B1 (en)* | 2016-02-04 | 2017-12-20 | 주식회사 강스템바이오텍 | Composition comprising GDF11 and uses thereof |
US10688222B2 (en) | 2016-11-21 | 2020-06-23 | Warsaw Orthopedic, Inc. | Lyophilized moldable implants containing an oxysterol |
US10639157B2 (en) | 2017-03-14 | 2020-05-05 | Theracell, Inc. | Demineralized bone fiber composition for use in minimally invasive surgery |
US11464888B2 (en) | 2017-06-12 | 2022-10-11 | Warsaw Orthopedic, Inc. | Moldable formulations containing an oxysterol in an acellular tissue matrix |
WO2019033082A1 (en) | 2017-08-11 | 2019-02-14 | Theracell, Inc. | Demineralized bone fiber composition for augmentation of fixation |
KR101893339B1 (en)* | 2017-09-19 | 2018-08-31 | 주식회사 강스템바이오텍 | Composition comprising GDF11 and uses thereof |
US11103618B2 (en) | 2018-02-22 | 2021-08-31 | Warsaw Orthopedic, Inc. | Demineralized bone matrix having improved handling characteristics |
CN109097425B (en)* | 2018-08-28 | 2022-06-07 | 浙江康嘉基因技术有限公司 | Polypeptide and application of polypeptide as influenza vaccine immunologic adjuvant |
WO2020163828A1 (en) | 2019-02-09 | 2020-08-13 | Theracell, Inc. | Demineralized bone fiber implant compositions and methods for augmenting fixation in bone repair |
US11498880B2 (en) | 2019-07-26 | 2022-11-15 | Warsaw Orthopedic, Inc. | Calcium phosphate granules and methods of making them |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991018047A2 (en)* | 1990-05-24 | 1991-11-28 | Genentech, Inc. | Mammalian expression of the bmp-2 family |
WO1991018098A1 (en)* | 1990-05-16 | 1991-11-28 | Genetics Institute, Inc. | Bone and cartilage inductive proteins |
WO1993000432A1 (en)* | 1991-06-25 | 1993-01-07 | Genetics Institute, Inc. | Bmp-9 compositions |
US5187076A (en)* | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
WO1996001845A1 (en)* | 1994-07-08 | 1996-01-25 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-11 |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
DE3382562D1 (en) | 1982-09-24 | 1992-06-25 | Us Health | ANIMAL TISSUE RECOVERY. |
US4588684A (en) | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
NZ210699A (en) | 1984-01-04 | 1989-06-28 | Int Genetic Eng | Isolation of an osteogenic protein of the p3 immunologically related family |
DK518384A (en) | 1984-01-31 | 1985-07-01 | Idaho Res Found | VECTOR FOR THE MANUFACTURE OF A GENE PRODUCT IN INSECT CELLS, PROCEDURE FOR ITS MANUFACTURING AND ITS USE |
CA1341617C (en) | 1984-06-08 | 2011-06-28 | Henry George Burger | Inhibin isolated from ovarian follicular fluid |
UA39161C2 (en) | 1984-07-06 | 2001-06-15 | Новартіс Аг | Recombinant protein of GM-CSF for increase in productION of granylocytes and macrophages by patients, vector and cdna coding it |
EP0169016B2 (en) | 1984-07-16 | 2004-04-28 | Celtrix Pharmaceuticals, Inc. | Polypeptide cartilage-inducing factors found in bone |
ATE78515T1 (en) | 1984-10-05 | 1992-08-15 | Genentech Inc | DNA, CELL CULTURES AND METHODS FOR HETEROLOGOUS PROTEIN SECRETION AND PERIPLASMIC PROTEIN RECOVERY. |
US4740587A (en)* | 1985-07-18 | 1988-04-26 | The Salk Institute For Biological Studies | Inhibin and method of purifying same |
US5089396A (en)* | 1985-10-03 | 1992-02-18 | Genentech, Inc. | Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
US5215893A (en)* | 1985-10-03 | 1993-06-01 | Genentech, Inc. | Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
NZ231899A (en)* | 1985-10-03 | 1991-07-26 | Genentech Inc | Human or porcine inhibin peptide compositions and dna encoding them |
US4798885A (en) | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
US4737578A (en)* | 1986-02-10 | 1988-04-12 | The Salk Institute For Biological Studies | Human inhibin |
IL83003A (en)* | 1986-07-01 | 1995-07-31 | Genetics Inst | Osteoinductive factors |
US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
ZA874681B (en) | 1986-07-01 | 1988-04-27 | Genetics Inst | Novel osteoinductive factors |
US5106748A (en) | 1986-07-01 | 1992-04-21 | Genetics Institute, Inc. | Dna sequences encoding 5 proteins |
US5108922A (en) | 1986-07-01 | 1992-04-28 | Genetics Institute, Inc. | DNA sequences encoding BMP-1 products |
US5041538A (en)* | 1987-08-28 | 1991-08-20 | The Salk Institute For Biological Studies | Mammalian follistatin |
US5168150A (en) | 1988-03-17 | 1992-12-01 | Electronique Serge Dassault | Device for the processing of a magnetic-track ticket, especially an air transport ticket |
US5071834A (en) | 1988-09-16 | 1991-12-10 | Genentech, Inc. | Purified activin B composition |
US5166190A (en)* | 1990-01-08 | 1992-11-24 | Genentech, Inc. | Method for increasing fertility in males |
EP0550625B1 (en)* | 1990-09-26 | 2003-11-05 | Genetics Institute, LLC | Bmp-5 derivatives |
JP3356775B2 (en)* | 1990-11-30 | 2002-12-16 | セルトリックス ファーマシューティカルズ, インコーポレイテッド | Use of osteogenic proteins for bone repair by co-combination with TGF-β |
US5208219A (en) | 1991-02-14 | 1993-05-04 | Celtrix Pharmaceuticals Inc. | Method for inducing bone growth |
CA2102808A1 (en)* | 1991-05-10 | 1992-11-11 | Hanne Bentz | Targeted delivery of bone growth factors |
US5171579A (en)* | 1991-10-11 | 1992-12-15 | Genetics Institute, Inc. | Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
ATE238417T1 (en)* | 1991-11-04 | 2003-05-15 | Inst Genetics Llc | RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE |
PT653942E (en) | 1992-07-31 | 2003-11-28 | Curis Inc | REGENERATION AND REPARATION OF MORPHOGENES INDUCED NERVES |
EP1333035A3 (en) | 1993-03-19 | 2004-07-07 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-8 |
ES2274157T3 (en)* | 1993-05-12 | 2007-05-16 | Genetics Institute, Llc | BMP-11 COMPOSITIONS. |
DE69433742T2 (en)* | 1993-05-12 | 2005-07-07 | Genetics Institute, LLC, Cambridge | BMP-10 COMPOSITIONS |
EP1716864A1 (en)* | 1993-08-26 | 2006-11-02 | Genetics Institute, LLC | Neural regeneration using home bone morphogenetic proteins |
US5545616A (en)* | 1994-09-22 | 1996-08-13 | Genentech, Inc. | Method for predicting and/or preventing preterm labor |
KR20000064752A (en) | 1996-03-22 | 2000-11-06 | 더 제네랄 호스피탈 코포레이션 | Administration of Polypeptide Growth Factor after Expression of Central Nervous System Ischemia or Trauma |
JP3361278B2 (en) | 1997-12-26 | 2003-01-07 | シャープ株式会社 | Reflection type liquid crystal display device, method for manufacturing the same, and method for manufacturing circuit board |
US6004937A (en)* | 1998-03-09 | 1999-12-21 | Genetics Institute, Inc. | Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11] |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5187076A (en)* | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
WO1991018098A1 (en)* | 1990-05-16 | 1991-11-28 | Genetics Institute, Inc. | Bone and cartilage inductive proteins |
WO1991018047A2 (en)* | 1990-05-24 | 1991-11-28 | Genentech, Inc. | Mammalian expression of the bmp-2 family |
US5168050A (en)* | 1990-05-24 | 1992-12-01 | Genentech, Inc. | Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion |
WO1993000432A1 (en)* | 1991-06-25 | 1993-01-07 | Genetics Institute, Inc. | Bmp-9 compositions |
WO1996001845A1 (en)* | 1994-07-08 | 1996-01-25 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-11 |
Title |
---|
PARALKAR V M ET AL: "Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: Potentiation and binding to type IV collagen", JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, NEW YORK, US, US, vol. 119, no. 6, 1992, pages 1721 - 1728, XP000576625, ISSN: 0021-9525* |
Publication | Publication Date | Title |
---|---|---|
EP1770161A3 (en) | BMP-11 compositions | |
EP0652107A3 (en) | Parallel printing device with modular structure and relative process for the production thereof. | |
AU5936094A (en) | Greeting and schedule integration arrangement | |
AU4225889A (en) | Peptide synthesis method and solid support for use in the method | |
CA2170143A1 (en) | Cell death regulator | |
AU3749493A (en) | Process for the low-temperature air separation and air separation plant | |
AU8067394A (en) | Benzylated wooden material and process for producing the same | |
AU1276095A (en) | Improvements in or relating to fuses | |
AU2024797A (en) | Improvement in the method and plant for manufacturing thermoplastic-resin parisons | |
AU6533294A (en) | Seating arrangements for cycles, exercice cycles, other pedal-powered contrivances and the like contrivances | |
AU3749393A (en) | Air separation plant and process for the low-temperature air separation | |
CA2087494A1 (en) | Soluble ldl receptor, its production and use | |
AU8829391A (en) | Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations | |
KR970000398B1 (en) | Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane | |
AU5837894A (en) | Improvements in or relating to camera pedestals | |
AU6774694A (en) | Taste-masking pharmaceutical compositions and methods for making the same | |
AU7622294A (en) | Improvements in and relating to the shaping of articles | |
AU6669894A (en) | Hybrid neuronal cell lines compositions and methods | |
Renecker | Bioenergetics and behavior of moose (Alces alces) in the aspen-dominated boreal forest | |
EP0445021A3 (en) | Tris acetyl-2",3",4'ethylidene-4",6"-beta-d-glucopyranosides, their production and use in the synthesis of ethylidene-beta-d-glucopyranosides of epipodophyllotoxin | |
AU7281296A (en) | Dispersions containing polyurethanes with carbonyl groups in the keto function | |
AU7997794A (en) | Improvements in connecting means | |
AU6197594A (en) | Copolymer produced in two stages | |
HU9402646D0 (en) | Anomere fluoro-ribosyl-amines | |
AU1485197A (en) | Diamines in the treatment of arrhythmia |
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
17P | Request for examination filed | Effective date:20061024 | |
AC | Divisional application: reference to earlier application | Ref document number:0698094 Country of ref document:EP Kind code of ref document:P Ref document number:1378572 Country of ref document:EP Kind code of ref document:P | |
AK | Designated contracting states | Kind code of ref document:A2 Designated state(s):AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE | |
PUAL | Search report despatched | Free format text:ORIGINAL CODE: 0009013 | |
AK | Designated contracting states | Kind code of ref document:A3 Designated state(s):AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE | |
AKX | Designation fees paid | Designated state(s):AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE | |
17Q | First examination report despatched | Effective date:20100326 | |
STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN | |
18D | Application deemed to be withdrawn | Effective date:20130103 |